3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
42
Lung Neoplasms
18
Melanoma
14
Carcinoma, Hepatocellular
14
Neoplasm Metastasis
13
Esophageal Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
9
Breast Neoplasms
8
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Rectal Neoplasms
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Recurrence
4
Neoplasms
4
Carcinoma, Renal Cell
4
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Radiation Pneumonitis
2
Pathologic Complete Response
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Oropharyngeal Neoplasms
2
Interventions
Gemcitabine
39
Cisplatin
24
Oxaliplatin
21
Capecitabine
20
Fluorouracil
11
Leucovorin
9
Irinotecan
9
130-nm albumin-bound paclitaxel
8
durvalumab
6
Taxes
5
Radiotherapy
5
Platinum
4
Immunohistochemistry
4
Erlotinib Hydrochloride
4
Docetaxel
4
Carboplatin
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
1,2-diaminocyclohexaneplatinum II citrate
4
trifluridine tipiracil drug combination
3
Trastuzumab
3
Sorafenib
3
Observation
3
Epirubicin
3
Drug Therapy
3
tremelimumab
2
toripalimab
2
regorafenib
2
pembrolizumab
2
anlotinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gallbladder Neoplasms
×
Immunotherapy
×
Clear all
NCT04333927
2020-06-23
ACCORD
Sun Yat-sen University
Phase 2
Unknown
92 enrolled